RPL10 and familial pancreatic carcinoma: Based on the experimental evidence in the present study, the anti-proliferative effects by DMAPT in pancreatic cancer cells are most likely the results of a synergetic action of RPL10 and its influence on the NF-κB pathway, which is illustrated in Figure 7.